Zobrazeno 1 - 10
of 10
pro vyhledávání: '"M. P. Deonarain"'
Autor:
Julie Richards, R Darbha, Dianne L. Newton, Bang K. Vu, Xinhua Ji, M. P. Deonarain, N S Courtenay-Luck, Juergen Krauss, Michaela A. E. Arndt, Susanna M. Rybak, Z Zhu, V Choudhry
Publikováno v:
British Journal of Cancer
Anti-MUC1 single-chain Fv (scFv) fragments generated from the humanised antibody huHMFG1 had adequate antigen-binding properties but very poor stability irrespective of the applied linker or domain orientation. Mutagenesis of heavy-chain framework re
Autor:
A. A. Epenetos, M. P. Deonarain
Publikováno v:
British Journal of Cancer
Bovine seminal ribonuclease (BSRNase) is an unusual member of the ribonuclease superfamily, because of its remarkable anti-tumour and immunosuppressive properties. We describe here the construction, expression, purification and characterization of a
Autor:
A. A. Epenetos, M. P. Deonarain
Publikováno v:
British Journal of Cancer
Enzymes which traditionally have played no role in cell-directed cytotoxicity are finding their way into schemes for prodrug activation and immunotoxins owing to such useful enzymatic activity. Alkaline phosphatase, carboxypeptidases, beta-glucosidas
Publikováno v:
Biotechnology letters. 32(5)
With the advent of antibody fragments and alternative binding scaffolds, that are devoid of Fc-regions, strategies to increase the half-life of small proteins are becoming increasingly important. Currently, the established method is chemical PEGylati
Publikováno v:
International journal of cancer. 86(4)
A number of mammalian proteins with suitable biological activities have been considered for use in targeted tumour therapy. Deoxyribonuclease-I (DNase-I), an endonuclease that degrades double-stranded DNA, represents an attractive candidate for tumou
Publikováno v:
Gene therapy. 2(4)
For many years, antibodies have been examined as means to deliver cytotoxic proteins to kill target cells (immunotoxins). More recently, there have been studies on enzymes that convert prodrugs to active drugs to kill target cells. The advances in ge
Publikováno v:
Gene therapy. 2(3)
The recent finding that inoculation with plasmids encoding a variety of proteins leads to T cell and antibody responses in vivo against these proteins provides a novel means of active specific immunisation by plasmid vaccination. The demonstration th
Autor:
M A Butt, R J Haidry, D Oukrif, H Pye, I Stamati, G Yahioglu, M Rodriguez-Justo, M R Banks, M P Deonarain, M R Novelli, L B Lovat
Publikováno v:
Gut. 61:A302.3-A303
Autor:
M A Butt, H Pye, R J Haidry, D Oukrif, M Rashid, M R Banks, M P Deonarain, M R Novelli, L B Lovat
Publikováno v:
Gut. 61:A301.1-A301
Autor:
A. Constantinou, A. A. Epenetos, D. Hreczuk-Hirst, S. Jain, M. Wright, K. A. Chester, M. P. Deonarain
Publikováno v:
Bioconjugate Chemistry; May2009, Vol. 20 Issue 5, p924-931, 8p